2023 was a tough year to the biopharma marketplace, with quite a few companies downsizing and restructuring their workforces to remain afloat. You will find signs of recovery, as mergers and acquisitions picked up through the pharmaceutical and life sciences sector within the latter Component of 2023 and possess ongoing https://sites.google.com/view/bio-sites/blog